{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:11:12Z","timestamp":1790392272599,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n<jats:title>Objectives<\/jats:title>\n<jats:p>Patients receiving glucocorticoid treatment are prone to develop metabolic complications. In preclinical studies, metformin prevented the development of the metabolic syndrome during glucocorticoid excess. We herein investigated the metabolic effect of metformin during glucocorticoid treatment in non-diabetic patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In a double-blind, placebo-controlled trial, patients starting glucocorticoid treatment (prednisone, prednisolone or methylprednisolone) for four weeks were randomised to concomitantly receive metformin (850\u2009mg once daily for one week followed by 850\u2009mg twice daily for three weeks) or placebo. All patients underwent a standardised oral glucose tolerance test at baseline and after four weeks. The primary endpoint was change in the 2-h area under the curve (AUC) of glucose during the oral glucose tolerance test between baseline and four weeks.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>29 of 34 randomised non-diabetic patients completed the trial (17 metformin and 12 placebo). In patients allocated to placebo, median glucose 2-h AUC increased from baseline to four weeks (836 (IQR 770\u2013966) to 1202 (1009\u20131271)\u2009mmol\/L per min; <jats:italic>P\u2009<\/jats:italic>=\u20090.01). In contrast, glucose levels remained similar to baseline in the metformin group (936 (869\u20131003) to 912 (825\u20131011)\u2009mmol\/L per min; <jats:italic>P\u2009<\/jats:italic>=\u20090.83). This change within four weeks was different between both groups (<jats:italic>P\u2009<\/jats:italic>=\u20090.005). Glucocorticoid equivalent doses were similar in both groups (placebo: 980.0 (560.0\u20133259.8)\u2009mg\/28 days; metformin: 683.0 (437.5\u20131970.5) mg\/28 days; <jats:italic>P\u2009<\/jats:italic>=\u20090.26).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this first randomised controlled trial of metformin targeting metabolic complications in patients needing glucocorticoid therapy, we observed a beneficial effect of metformin on glycaemic control. Metformin thus seems to be a promising drug for preventing metabolic side effects during systemic glucocorticoid treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1530\/eje-16-0653","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T02:50:33Z","timestamp":1484103033000},"page":"349-358","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":48,"title":["Metformin prevents metabolic side effects during systemic glucocorticoid treatment"],"prefix":"10.1093","volume":"176","author":[{"given":"Eleonora","family":"Seelig","sequence":"first","affiliation":[{"name":"1Department of EndocrinologyDiabetology and Metabolism, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Meyer","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyDiabetology and Metabolism, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Timper","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyDiabetology and Metabolism, University Hospital Basel, Basel, Switzerland"},{"name":"2Max-Planck-Institute for Metabolism ResearchCologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Nigro","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyDiabetology and Metabolism, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bally","sequence":"additional","affiliation":[{"name":"3Division of EndocrinologyDiabetology and Metabolism, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Pernicova","sequence":"additional","affiliation":[{"name":"4Department of EndocrinologyWilliam Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schuetz","sequence":"additional","affiliation":[{"name":"3Division of EndocrinologyDiabetology and Metabolism, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"3Division of EndocrinologyDiabetology and Metabolism, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Korbonits","sequence":"additional","affiliation":[{"name":"4Department of EndocrinologyWilliam Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyDiabetology and Metabolism, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2017020317102841000_176.3.349.1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.2.105"},{"key":"2017020317102841000_176.3.349.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030871"},{"key":"2017020317102841000_176.3.349.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.02067.x"},{"key":"2017020317102841000_176.3.349.4","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1499"},{"key":"2017020317102841000_176.3.349.5","doi-asserted-by":"publisher","DOI":"10.4158\/EP08331.RAR"},{"key":"2017020317102841000_176.3.349.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151464"},{"key":"2017020317102841000_176.3.349.7","doi-asserted-by":"publisher","DOI":"10.1159\/000097598"},{"key":"2017020317102841000_176.3.349.8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.4143\/crt.2015.464","article-title":"A pilot study evaluating steroid-induced diabetes after antiemetic dexamethasone therapy in chemotherapy-treated cancer patients","volume":"48","author":"Jeong","year":"2016","journal-title":"Cancer Research and Treatment"},{"key":"2017020317102841000_176.3.349.9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/metabo6030024","article-title":"Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence","volume":"6","author":"Pasieka","year":"2016","journal-title":"Metabolites"},{"key":"2017020317102841000_176.3.349.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2004.12.003"},{"key":"2017020317102841000_176.3.349.11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1120781"},{"key":"2017020317102841000_176.3.349.12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113505"},{"key":"2017020317102841000_176.3.349.13","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-094144"},{"key":"2017020317102841000_176.3.349.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1297"},{"key":"2017020317102841000_176.3.349.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.09.018"},{"key":"2017020317102841000_176.3.349.16","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0192"},{"key":"2017020317102841000_176.3.349.17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/evj.12068","article-title":"Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses","volume":"45","author":"Rendle","year":"2013","journal-title":"Equine Veterinary Journal"},{"key":"2017020317102841000_176.3.349.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00151-8"},{"key":"2017020317102841000_176.3.349.19","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90233-9"},{"key":"2017020317102841000_176.3.349.20","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"2017020317102841000_176.3.349.21","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00125-013-3016-8","article-title":"Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial","volume":"56","author":"van Raalte","year":"2013","journal-title":"Diabetologia"},{"key":"2017020317102841000_176.3.349.22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-1034"},{"key":"2017020317102841000_176.3.349.23","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-14-0373"},{"key":"2017020317102841000_176.3.349.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00297-8"},{"key":"2017020317102841000_176.3.349.25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2337\/diacare.24.4.788","article-title":"Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM","volume":"24","author":"Morita","year":"2001","journal-title":"Diabetes Care"},{"key":"2017020317102841000_176.3.349.26","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1677"},{"key":"2017020317102841000_176.3.349.27","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0610"},{"key":"2017020317102841000_176.3.349.28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200525102"},{"key":"2017020317102841000_176.3.349.29","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.256"},{"key":"2017020317102841000_176.3.349.30","doi-asserted-by":"publisher","DOI":"10.1038\/nature13270"},{"key":"2017020317102841000_176.3.349.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1937-z"},{"key":"2017020317102841000_176.3.349.32","doi-asserted-by":"publisher","DOI":"10.1038\/nature11808"},{"key":"2017020317102841000_176.3.349.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.03.016"},{"key":"2017020317102841000_176.3.349.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.05.005"},{"key":"2017020317102841000_176.3.349.35","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0545"},{"key":"2017020317102841000_176.3.349.36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0524"},{"key":"2017020317102841000_176.3.349.37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/art.21329","article-title":"Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey","volume":"53","author":"Choi","year":"2005","journal-title":"Arthritis & Rheumatology"},{"key":"2017020317102841000_176.3.349.38","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.842"},{"key":"2017020317102841000_176.3.349.39","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s10067-015-3049-0","article-title":"Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment","volume":"34","author":"Akiyama","year":"2015","journal-title":"Clinical Rheumatology"},{"key":"2017020317102841000_176.3.349.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508313330902"},{"key":"2017020317102841000_176.3.349.41","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549050-00007"},{"key":"2017020317102841000_176.3.349.42","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.10.1100"},{"key":"2017020317102841000_176.3.349.43","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.170.2.2911678"},{"key":"2017020317102841000_176.3.349.44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.998"},{"key":"2017020317102841000_176.3.349.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"2017020317102841000_176.3.349.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602293340906"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/176\/3\/349.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-16-0653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:34:39Z","timestamp":1676392479000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/176\/3\/349\/6655137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":46,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/eje-16-0653","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}